Cargando…
Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate
Glioblastoma (GBM) is the deadliest type of brain tumor, and glioma stem cells (GSCs) contribute to tumor recurrence and therapeutic resistance. Thus, an oncolytic virus targeting GSCs may be useful for improving GBM treatment. Because Zika virus (ZIKV) has an oncolytic tropism for infecting GSCs, w...
Autores principales: | Chen, Qi, Wu, Jin, Ye, Qing, Ma, Feng, Zhu, Qian, Wu, Yan, Shan, Chao, Xie, Xuping, Li, Dapei, Zhan, Xiaoyan, Li, Chunfeng, Li, Xiao-Feng, Qin, Xiaoling, Zhao, Tongyang, Wu, Haitao, Shi, Pei-Yong, Man, Jianghong, Qin, Cheng-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143740/ https://www.ncbi.nlm.nih.gov/pubmed/30228241 http://dx.doi.org/10.1128/mBio.01683-18 |
Ejemplares similares
-
Erratum for Chen et al., “Treatment of Human Glioblastoma with a Live Attenuated Zika Virus Vaccine Candidate”
por: Chen, Qi, et al.
Publicado: (2019) -
Oncolytic Zika virus promotes intratumoral T cell infiltration and improves immunotherapy efficacy in glioblastoma
por: Chen, Lishu, et al.
Publicado: (2022) -
A single-dose live attenuated chimeric vaccine candidate against Zika virus
por: Chin, Wei-Xin, et al.
Publicado: (2021) -
Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone
por: Li, Xiao-Feng, et al.
Publicado: (2018) -
Using Next Generation Sequencing to Study the Genetic Diversity of Candidate Live Attenuated Zika Vaccines
por: Collins, Natalie D., et al.
Publicado: (2020)